Gilot B, Gonzalez D, Bournazeau J A, Barriére A, Van Lieferinghen P
Service de Psychiatrie d'Adultes, CHU G. Montpied, Clermont-Ferrand.
Encephale. 1999 Nov-Dec;25(6):590-4.
The treatment for psychiatric disorders in pregnancy remains difficult to implement. We report the case of a 28-year-old woman, 20 weeks pregnant when admitted in our psychiatric department. She presented severe depressive disorder, associated with agitation, and psychotic symptoms as delusion and hallucinations occurred. The patient had a history of recurrent mood disorders dating back to eight years before the current admission, including some atypical episodes (psychotic symptoms only), and alternating with free periods without any trouble. A non-specific personality disorder is also probably present. We first used antidepressant (clomipramine) and sedative phenothiazine drugs. Because of the lack of therapeutic efficacy, three weeks later we tried another pharmacologic prescription, that also failed to improve the patient' status. It was hence decided to proceed with electroconvulsive therapy. We describe here the management of the courses, especially the careful monitoring and the anesthetic features we employed, among which endotracheal intubation, oxygen supply, real-time ultrasonography, and recording uterine contractions and fetal heart rate. All theses measures were applied within a surgical-obstetrical theatre. Nine bifrontal courses were performed in five weeks. They rapidly and completely improved the psychiatric symptoms. No sign of fetal neither maternal bad tolerance occurred. While the patient had been authorized to leave hospital, in 34th weeks amenorrhea a routine ultrasonographic examination discovered worrying fetal ascites signs. After the emergency caesarean delivery, the male newborn child undergone immediately surgical treatment for vascular meconium peritonitis, but died nine days later with metabolic post-surgical troubles. This fatal outcome after electroconvulsive therapy leads us to discuss its possible involvement, and in a more general way the safety and place of this treatment in pregnancy psychiatric disorders. They remain critical situations in which therapeutic methods should be rapidly decided. The authors wish others practitioners to bring new case-reports in order to assess the ECT safety-use during pregnancy.
孕期精神疾病的治疗仍然难以实施。我们报告一例28岁女性病例,其入院时怀孕20周,入住我们的精神科。她表现为严重的抑郁症,伴有躁动,出现妄想和幻觉等精神病症状。该患者有反复情绪障碍病史,可追溯到本次入院前八年,包括一些非典型发作(仅有精神病症状),并与无任何问题的缓解期交替出现。也可能存在非特异性人格障碍。我们首先使用了抗抑郁药(氯米帕明)和镇静性吩噻嗪类药物。由于缺乏治疗效果,三周后我们尝试了另一种药物处方,但也未能改善患者状况。因此决定进行电休克治疗。我们在此描述治疗过程的管理,特别是我们采用的仔细监测和麻醉特点,其中包括气管插管、供氧、实时超声检查以及记录子宫收缩和胎儿心率。所有这些措施均在外科产科手术室实施。在五周内进行了九次双额叶治疗。这些治疗迅速且完全改善了精神症状。未出现胎儿或母亲耐受性差的迹象。当患者被允许出院时,在停经第34周时,一次常规超声检查发现了令人担忧的胎儿腹水迹象。紧急剖宫产术后,男婴立即接受了血管性胎粪性腹膜炎的手术治疗,但九天后因术后代谢问题死亡。电休克治疗后的这一致命结果促使我们讨论其可能的影响,并更广泛地讨论这种治疗在孕期精神疾病中的安全性和地位。它们仍然是需要迅速决定治疗方法的危急情况。作者希望其他从业者能提供新的病例报告,以评估孕期电休克治疗的安全使用情况。